Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Elastin synthesis stimulation" refers to therapeutic interventions or strategies that increase the production of elastin, the stretchable structural protein essential for the elasticity of tissues such as blood vessels, lungs, and skin. Elastin is produced by the crosslinking of tropoelastin monomers, a process regulated by a range of signals and affected by age, disease, and environmental factors. Certain drugs, such as minoxidil, have been shown to upregulate elastin gene expression and promote the assembly of new elastic fibers, leading to potential benefits in conditions related to arterial stiffness, aging, and cardiovascular disease. However, "elastin synthesis stimulation" is not itself a defined molecular target but a physiological process or approach influenced by various genes, enzymes, and cellular pathways.
Modulation of gene expression (e.g., minoxidil increasing elastin mRNA via Ca²⁺-ERK pathway)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Elastin synthesis stimulation.